Metabolic syndrome: updates on pathophysiology and management in 2021
Metabolic syndrome (MetS) forms a cluster of metabolic dysregulations including insulin
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
resistance, atherogenic dyslipidemia, central obesity, and hypertension. The pathogenesis …
Anabolic–androgenic steroids: How do they work and what are the risks?
Anabolic–androgenic steroids (AAS) are a class of hormones that are widely abused for
their muscle-building and strength-increasing properties in high, nontherapeutic, dosages …
their muscle-building and strength-increasing properties in high, nontherapeutic, dosages …
[HTML][HTML] PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
M Banach, P Burchardt, K Chlebus… - Archives of Medical …, 2021 - ncbi.nlm.nih.gov
Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …
Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?
Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …
[HTML][HTML] Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials
Background Maternal vitamin D deficiency has been associated with an increased risk for
preeclampsia. Despite this, the current evidence regarding the efficacy of vitamin D …
preeclampsia. Despite this, the current evidence regarding the efficacy of vitamin D …
Efficacy and safety of mipomersen: a systematic review and meta-analysis of randomized clinical trials
Aim Our aim was to assess the efficacy and safety of mipomersen through a systematic
review of the literature and a meta-analysis of the available clinical studies. Methods A …
review of the literature and a meta-analysis of the available clinical studies. Methods A …
[HTML][HTML] Red yeast rice for hypercholesterolemia
The extract of red yeast rice (RYR) is the most effective cholesterol-lowering nutraceutical on
the market. In particular, its effectiveness is directly related to the amount of monacolin K …
the market. In particular, its effectiveness is directly related to the amount of monacolin K …
[HTML][HTML] Bioactive compounds from herbal medicines to manage dyslipidemia
X Ji, S Shi, B Liu, M Shan, D Tang, W Zhang… - Biomedicine & …, 2019 - Elsevier
Dyslipidemia is a key risk factor for cardiovascular diseases, which are a major cause of
morbidity and mortality worldwide. However, despite the advancement of the treatment and …
morbidity and mortality worldwide. However, despite the advancement of the treatment and …
Red yeast rice for the improvement of lipid profiles in mild-to-moderate hypercholesterolemia: a narrative review
Reducing low-density lipoprotein cholesterol (LDL-C) levels is a key target for lowering
cardiovascular risk and preventing atherosclerotic cardiovascular disease (ASCVD). Red …
cardiovascular risk and preventing atherosclerotic cardiovascular disease (ASCVD). Red …
Red yeast rice preparations reduce mortality, major cardiovascular adverse events, and risk factors for metabolic syndrome: A systematic review and meta− analysis
R Yuan, Y Yuan, L Wang, Q Xin, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Background: Metabolic syndrome (MetS) is characterized by the cooccurrence of obesity,
insulin resistance, dyslipidaemia, and hypertension. Red yeast rice (RYR) preparations …
insulin resistance, dyslipidaemia, and hypertension. Red yeast rice (RYR) preparations …